---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-087838"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:31:02.863363+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zura Bio reports 97.2% of public warrants and 69% of private warrants tendered in exchange offer

## Summary
- 6,703,428 public warrants (~97.2%) and 4,080,580 private placement warrants (~69.0%) validly tendered; settlement expected by Aug 12, 2024.
- Each tendered warrant exchanged for 0.30 Class A ordinary shares; remaining untendered warrants to be converted into 0.27 shares (10% less).
- Consents received to amend warrant agreement; post-offer exchange will eliminate all outstanding IPO warrants.
- Cantor Fitzgerald acted as dealer manager; Alliance Advisors as information agent.

## SEC filing metadata
- accession: 0001104659-24-087838
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/0001104659-24-087838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/tm2421034d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-087838
- JSON: https://secwatch.observer/filing/0001104659-24-087838.json
- Plain text: https://secwatch.observer/filing/0001104659-24-087838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.